Company Completely Halts Generic Lipi...

Company Completely Halts Generic Lipitor Production After Recall

There are 1 comment on the The Huffington Post story from Nov 29, 2012, titled Company Completely Halts Generic Lipitor Production After Recall. In it, The Huffington Post reports that:

Indian generic drugmaker Ranbaxy Laboratories will stop manufacturing its version of Pfizer Inc's cholesterol fighter, Lipitor, while it gets to the bottom of the cause of a recent recall, the U.S. Food and Drug Administration said on its website.

Join the discussion below, or Read more at The Huffington Post.

Pharmaman

Somerset, NJ

#1 Dec 6, 2012
No matter what the result of Ranbaxy's invesigation,it will lose 90% of its generic atorvastating business in the US. market which would have been $ 150 mm +in 2013.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Ranbaxy Laboratories Discussions

Title Updated Last By Comments
News Ranbaxy announces USFDA approval of CIP-Isotret... (Aug '12) Sep '13 De Croft 9
News Mylan Inc. Tries to Get Its Hands on Ranbaxy La... (Dec '12) Dec '12 Jrseyan 1
More from around the web